KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Progyny (PGNY) Equity Average (2018 - 2025)

Progyny (PGNY) has disclosed Equity Average for 8 consecutive years, with $538.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Equity Average changed N/A to $538.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $538.0 million, a N/A change, with the full-year FY2023 number at $465.2 million, up 47.97% from a year prior.
  • Equity Average was $538.0 million for Q4 2025 at Progyny, roughly flat from $537.5 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $562.5 million in Q1 2024 to a low of $175.8 million in Q1 2021.
  • A 5-year average of $394.1 million and a median of $445.5 million in 2024 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: soared 75.25% in 2021, then decreased 19.82% in 2025.
  • Progyny's Equity Average stood at $238.0 million in 2021, then soared by 52.08% to $361.9 million in 2022, then skyrocketed by 47.66% to $534.4 million in 2023, then fell by 16.63% to $445.5 million in 2024, then grew by 20.76% to $538.0 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Equity Average are $538.0 million (Q4 2025), $537.5 million (Q3 2025), and $491.1 million (Q2 2025).